[Innovation by TaNeDS (Take a New challenge of Drug diScovery) collaborative drug discovery project].
作者信息
Fujita Yoshifumi
出版信息
Nihon Yakurigaku Zasshi. 2013 Aug;142(2):89-95. doi: 10.1254/fpj.142.89.
PMID:23934529
Abstract
摘要
相似文献
1
[Innovation by TaNeDS (Take a New challenge of Drug diScovery) collaborative drug discovery project].
Nihon Yakurigaku Zasshi. 2013 Aug;142(2):89-95. doi: 10.1254/fpj.142.89.
2
[Open innovation for Japanese pharmaceutical companies].
Nihon Yakurigaku Zasshi. 2013 Oct;142(4):184-9. doi: 10.1254/fpj.142.184.
3
[Open innovation: public-private partnerships in pharmaceutical R&D].
Nihon Yakurigaku Zasshi. 2013 Jul;142(1):32-8. doi: 10.1254/fpj.142.32.
4
Why and how have drug discovery strategies in pharma changed? What are the new mindsets?
Drug Discov Today. 2016 Feb;21(2):239-49. doi: 10.1016/j.drudis.2015.09.007. Epub 2015 Sep 14.
5
The current state of drug discovery and what it might take to improve drug discovery outcomes and approval successes.
Drug Discov Today. 2015 Aug;20(8):917-9. doi: 10.1016/j.drudis.2015.06.005. Epub 2015 Jun 19.
6
The future of discovery chemistry: quo vadis? Academic to industrial--the maturation of medicinal chemistry to chemical biology.
Drug Discov Today. 2010 Apr;15(7-8):260-4. doi: 10.1016/j.drudis.2010.02.002. Epub 2010 Feb 10.
7
[Open innovation and licensing in the pharmaceutical industry].
Nihon Yakurigaku Zasshi. 2013 Jul;142(1):28-31. doi: 10.1254/fpj.142.28.
8
Open innovation: share or die..
Drug Discov Today. 2009 Nov;14(21-22):1003-5. doi: 10.1016/j.drudis.2009.09.001. Epub 2009 Sep 22.
9
Deconstructing the drug development process: the new face of innovation.
Clin Pharmacol Ther. 2010 Mar;87(3):356-61. doi: 10.1038/clpt.2009.293. Epub 2010 Feb 3.
10
[Open innovation for pharmaceutical industries].
Nihon Yakurigaku Zasshi. 2013 Apr;141(4):199-204. doi: 10.1254/fpj.141.199.
Zotero 插件